MiR-30c protects diabetic nephropathy by suppressing epithelial-to-mesenchymal transition in db/db mice

被引:101
|
作者
Zhao, Yanru [1 ]
Yin, Zhongwei [1 ]
Li, Huaping [1 ]
Fan, Jiahui [1 ]
Yang, Shenglan [2 ]
Chen, Chen [1 ]
Wang, Dao Wen [1 ]
机构
[1] Huazhong Univ Sci & Technol, Div Cardiol, Dept Internal Med, Tongji Hosp,Tongji Med Coll, 1095 Jiefang Ave, Wuhan 430030, Peoples R China
[2] Chongqing Med Univ, Dept Cardiol, Affiliated Hosp 1, Chongqing 400042, Peoples R China
来源
AGING CELL | 2017年 / 16卷 / 02期
基金
中国国家自然科学基金;
关键词
diabetic nephropathy; epithelial-to-mesenchymal transition; miR-30c; Snail1; TGF-1; TRANSCRIPTION FACTOR SNAIL; KIDNEY FIBROSIS; RENAL FIBROSIS; DISEASE; EXPRESSION; TARGETS; GROWTH; CANCER; MOUSE; CELLS;
D O I
10.1111/acel.12563
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Epithelial-to-mesenchymal transition (EMT) plays a significant role in tubulointerstitial fibrosis, which is a hallmark of diabetic nephropathy. Thus, identifying the mechanisms of EMT activation could be meaningful. In this study, loss of miR-30c accompanied with increased EMT was observed in renal tubules of db/db mice and cultured HK2 cells exposed to high glucose. To further explore the roles of miR-30c in EMT and tubulointerstitial fibrosis, recombinant adeno-associated viral vector was applied to manipulate the expression of miR-30c. In vivo study showed that overexpression of miR-30c suppressed EMT, attenuated renal tubulointerstitial fibrosis and reduced proteinuria, serum creatinine, and BUN levels. In addition, Snail1 was identified as a direct target of miR-30c by Ago2 co-immunoprecipitation, luciferase reporter, and Western blot assays. Downregulating Snail1 by siRNA reduced high glucose-induced EMT in HK2 cells, and miR-30c mimicked the effects. Moreover, miR-30c inhibited Snail1-TGF-1 axis in tubular epithelial cells undergoing EMT and thereby impeded the release of TGF-1; oppositely, knockdown of miR-30c enhanced the secretion of TGF-1 from epitheliums and significantly promoted proliferation of fibroblasts and fibrogenesis of myofibroblasts, aggravated tubulointerstitial fibrosis, and dysfunction of diabetic nephropathy. These results suggest a protective role of miR-30c against diabetic nephropathy by suppressing EMT via inhibiting Snail1-TGF-1 pathway.
引用
收藏
页码:387 / 400
页数:14
相关论文
共 50 条
  • [21] LncRNA OIP5-AS1 INDUCES EPITHELIAL-TO-MESENCHYMAL TRANSITION AND RENAL FIBROSIS IN DIABETIC NEPHROPATHY VIA BINDING TO miR-30c-5p
    Fu, J-X
    Sun, G-Q
    Wang, H-L
    Jiang, H-X
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2020, 34 (03): : 961 - 968
  • [22] Telmisartan attenuates diabetic nephropathy by suppressing oxidative stress in db/db mice (vol 121, pg e97, 2012)
    Sato-Horiguchi, C.
    Ogawa, D.
    Wada, J.
    Tachibana, H.
    Kodera, R.
    Eguchi, J.
    Nakatsuka, A.
    Terami, N.
    Shikata, K.
    Makino, H.
    NEPHRON EXPERIMENTAL NEPHROLOGY, 2013, 123 (3-4): : 46 - 46
  • [23] C3a Mediates Epithelial-to-Mesenchymal Transition in Proteinuric Nephropathy
    Tang, Ziyong
    Lu, Bao
    Hatch, Ellen
    Sacks, Steven H.
    Sheerin, Neil S.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 20 (03): : 593 - 603
  • [24] Downregulation of miR-30c promotes renal fibrosis by target CTGF in diabetic nephropathy
    Wang, Jinyang
    Duan, Lijun
    Guo, Tiankang
    Gao, Yanbin
    Tian, Limin
    Liu, Jing
    Wang, Shaocheng
    Yang, Jinkui
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2016, 30 (03) : 406 - 414
  • [25] MiR-30a increases cisplatin sensitivity of gastric cancer cells through suppressing epithelial-to-mesenchymal transition (EMT)
    Wang, L. -L.
    Zhang, X. -H.
    Zhang, X.
    Chu, J. -K.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2016, 20 (09) : 1733 - 1739
  • [26] Tongxinluo ameliorates renal structure and function by regulating miR-21-induced epithelial-to-mesenchymal transition in diabetic nephropathy
    Wang, Jin-yang
    Gao, Yan-bin
    Zhang, Na
    Zou, Da-wei
    Xu, Li-ping
    Zhu, Zhi-yao
    Li, Jiao-yang
    Zhou, Sheng-nan
    Cui, Fang-qiang
    Zeng, Xiang-jun
    Geng, Jian-guo
    Yang, Jin-kui
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2014, 306 (05) : F486 - F495
  • [27] MiR-30c/PGC-1β protects against diabetic cardiomyopathy via PPARα
    Yin, Zhongwei
    Zhao, Yanru
    He, Mengying
    Li, Huaping
    Fan, Jiahui
    Nie, Xiang
    Yan, Mengwen
    Chen, Chen
    Wang, Dao Wen
    CARDIOVASCULAR DIABETOLOGY, 2019, 18 (1)
  • [28] EFFECTS OF DANGGUI SHAOYAO POWDER ON DIABETIC NEPHROPATHY VIA INHIBITING EPITHELIAL-TO-MESENCHYMAL TRANSITION
    Li, X. B.
    Wang, J. M.
    Chen, Y. L.
    Xie, Z. L.
    Zhan, J. P.
    Liu, X. H.
    Zhang, Y. T.
    Li, R. Q.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2016, 118 : 17 - 17
  • [29] PHARMACOLOGICAL INHIBITION OF FATTY ACID BINDING PROTEIN-4 (FABP4) PROTECTS AGAINST DIABETIC NEPHROPATHY IN DB/DB MICE
    Shi, Min
    Ma, Liang
    Fu, Ping
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33
  • [30] Irbesartan Ameliorates Diabetic Nephropathy by Suppressing the RANKL-RANK-NF-κB Pathway in Type 2 Diabetic db/db Mice (vol 2016, 1405924, 2016)
    Chen, Xiao-Wen
    Du, Xiao-Yan
    Wang, Yu-Xian
    Wang, Jian-Cheng
    Liu, Wen-Ting
    Chen, Wen-Jing
    Li, Hong-Yu
    Peng, Fen-Fen
    Xu, Zhao-Zhong
    Niu, Hong-Xin
    Long, Hai-Bo
    MEDIATORS OF INFLAMMATION, 2016, 2016